8 results on '"Xue-Jia Hu"'
Search Results
2. Prokaryotic and Highly-Repetitive WD40 Proteins: A Systematic Study
- Author
-
Zhi-Qiang Ye, Yang Wang, Yun-Dong Wu, Tuan Li, Yao Xiong, Xian-Hui Wu, De-Lin Zhang, and Xue-Jia Hu
- Subjects
0301 basic medicine ,Cyanobacteria ,WD40 Repeats ,Proteome ,Protein family ,lcsh:Medicine ,Article ,Evolution, Molecular ,03 medical and health sciences ,Bacterial Proteins ,Protein Domains ,WD40 repeat ,Phylogenetics ,Gene duplication ,Humans ,lcsh:Science ,Phylogeny ,Genetics ,Multidisciplinary ,biology ,Gene Expression Profiling ,lcsh:R ,Planctomycetes ,Computational Biology ,Molecular Sequence Annotation ,biology.organism_classification ,Sequence identity ,Eukaryotic Cells ,030104 developmental biology ,Prokaryotic Cells ,Evolutionary biology ,Multigene Family ,lcsh:Q ,Signal transduction - Abstract
As an ancient protein family, the WD40 repeat proteins often play essential roles in fundamental cellular processes in eukaryotes. Although investigations of eukaryotic WD40 proteins have been frequently reported, prokaryotic ones remain largely uncharacterized. In this paper, we report a systematic analysis of prokaryotic WD40 proteins and detailed comparisons with eukaryotic ones. About 4,000 prokaryotic WD40 proteins have been identified, accounting for 6.5% of all WD40s. While their abundances are less than 0.1% in most prokaryotes, they are enriched in certain species from Cyanobacteria and Planctomycetes, and participate in various functions such as prokaryotic signal transduction and nutrient synthesis. Comparisons show that a higher proportion of prokaryotic WD40s tend to contain multiple WD40 domains and a large number of hydrogen bond networks. The observation that prokaryotic WD40 proteins tend to show high internal sequence identity suggests that a substantial proportion of them (~20%) should be formed by recent or young repeat duplication events. Further studies demonstrate that the very young WD40 proteins, i.e., Highly-Repetitive WD40s, should be of higher stability. Our results have presented a catalogue of prokaryotic WD40 proteins, and have shed light on their evolutionary origins.
- Published
- 2017
- Full Text
- View/download PDF
3. Genome-wide Analysis of WD40 Protein Family in Human
- Author
-
Xue-Jia Hu, Zhi-Qiang Ye, Yun-Dong Wu, Jing Ma, Xudong Zou, and Tuan Li
- Subjects
0301 basic medicine ,Protein family ,Lineage (evolution) ,In silico ,Sequence alignment ,Computational biology ,Biology ,Genome ,Article ,Evolution, Molecular ,03 medical and health sciences ,0302 clinical medicine ,Phylogenetics ,Animals ,Cluster Analysis ,Humans ,Amino Acid Sequence ,Gene ,Phylogeny ,Plant Proteins ,Multidisciplinary ,Genome, Human ,Microfilament Proteins ,Plants ,030104 developmental biology ,030220 oncology & carcinogenesis ,Multigene Family ,Human genome ,Sequence Alignment - Abstract
The WD40 proteins, often acting as scaffolds to form functional complexes in fundamental cellular processes, are one of the largest families encoded by the eukaryotic genomes. Systematic studies of this family on genome scale are highly required for understanding their detailed functions, but are currently lacking in the animal lineage. Here we present a comprehensive in silico study of the human WD40 family. We have identified 262 non-redundant WD40 proteins, and grouped them into 21 classes according to their domain architectures. Among them, 11 animal-specific domain architectures have been recognized. Sequence alignment indicates the complicated duplication and recombination events in the evolution of this family. Through further phylogenetic analysis, we have revealed that the WD40 family underwent more expansion than the overall average in the evolutionary early stage, and the early emerged WD40 proteins are prone to domain architectures with fundamental cellular roles and more interactions. While most widely and highly expressed human WD40 genes originated early, the tissue-specific ones often have late origin. These results provide a landscape of the human WD40 family concerning their classification, evolution, and expression, serving as a valuable complement to the previous studies in the plant lineage.
- Published
- 2016
- Full Text
- View/download PDF
4. (AEDPH3)·(ureaH)·(H2O): A Novel Organic Supramolecular Plaster with Gas Adsorption Performance
- Author
-
Ling-ling Pan, Yi-xuan Yuan, Liangjie Yuan, Xue-Jia Hu, Le Hu, and Shuoping Chen
- Subjects
Thermogravimetric analysis ,Gypsum ,Chemistry ,Supramolecular chemistry ,Infrared spectroscopy ,Mineralogy ,General Chemistry ,engineering.material ,Condensed Matter Physics ,Thermogravimetry ,Adsorption ,Chemical engineering ,Elemental analysis ,engineering ,General Materials Science ,Powder diffraction - Abstract
A novel supramolecular plaster, namely (AEDPH3)·(ureaH)·(H2O) (1), is synthesized and characterized by infrared spectrum (IR), thermogravimetric analysis (TGA), elemental analysis (EA), single-crystal X-ray diffraction (SCD), and powder X-ray diffraction (PXRD). The supramolecular plaster is an organic acid−base compound that shows a 3D hydrogen-bonded supramolecular network with extended 1D channels. It is simple to synthesize and process and shows good mechanical properties similar to the gypsum-based plaster. Moreover, it has nice gas adsorption performance.
- Published
- 2009
- Full Text
- View/download PDF
5. Non-manifesting AHI1 truncations indicate localized loss-of-function tolerance in a severe Mendelian disease gene
- Author
-
Hanno J. Bolz, Raoul Heller, Solaf M. Elsayed, Yun-Dong Wu, Holger Thiele, Gudrun Nürnberg, Friederike Körber, Inga Ebermann, Michaela Thoenes, Janine Altmüller, Ghada M H Abdel-Salam, Xue-Jia Hu, Eugen Boltshauser, Jennifer B. Phillips, Monte Westerfield, Saskia Seland, Ezzat Elsobky, Maha S. Zaki, Joseph G. Gleeson, Peter Nürnberg, Mohammad R. Toliat, University of Zurich, and Bolz, Hanno J
- Subjects
Male ,Models, Molecular ,Protein Conformation ,DNA Mutational Analysis ,medicine.disease_cause ,Consanguinity ,Cerebellum ,Gene Order ,Missense mutation ,Exome ,Eye Abnormalities ,Genetics (clinical) ,Exome sequencing ,Zebrafish ,Genetics ,Mutation ,Homozygote ,Brain ,Chromosome Mapping ,High-Throughput Nucleotide Sequencing ,General Medicine ,Articles ,Kidney Diseases, Cystic ,Disease gene identification ,Magnetic Resonance Imaging ,Pedigree ,Female ,Heterozygote ,2716 Genetics (clinical) ,Genes, Recessive ,610 Medicine & health ,Biology ,Joubert syndrome ,Retina ,Evolution, Molecular ,1311 Genetics ,medicine ,1312 Molecular Biology ,Animals ,Humans ,Abnormalities, Multiple ,Molecular Biology ,Gene ,Loss function ,Genetic Association Studies ,Adaptor Proteins, Signal Transducing ,medicine.disease ,Ciliopathy ,Adaptor Proteins, Vesicular Transport ,Disease Models, Animal ,Genetic Loci ,10036 Medical Clinic - Abstract
Determination of variant pathogenicity represents a major challenge in the era of high-throughput sequencing. Erroneous categorization may result if variants affect genes that are in fact dispensable. We demonstrate that this also applies to rare, apparently unambiguous truncating mutations of an established disease gene. By whole-exome sequencing (WES) in a consanguineous family with congenital non-syndromic deafness, we unexpectedly identified a homozygous nonsense variant, p.Arg1066*, in AHI1, a gene associated with Joubert syndrome (JBTS), a severe recessive ciliopathy. None of four homozygotes expressed any signs of JBTS, and one of them had normal hearing, which also ruled out p.Arg1066* as the cause of deafness. Homozygosity mapping and WES in the only other reported JBTS family with a homozygous C-terminal truncation (p.Trp1088Leufs*16) confirmed AHI1 as disease gene, but based on a more N-terminal missense mutation impairing WD40-repeat formation. Morpholinos against N-terminal zebrafish Ahi1, orthologous to where human mutations cluster, produced a ciliopathy, but targeting near human p.Arg1066 and p.Trp1088 did not. Most AHI1 mutations in JBTS patients result in truncated protein lacking WD40-repeats and the SH3 domain; disease was hitherto attributed to loss of these protein interaction modules. Our findings indicate that normal development does not require the C-terminal SH3 domain. This has far-reaching implications, considering that variants like p.Glu984* identified by preconception screening ('Kingsmore panel') do not necessarily indicate JBTS carriership. Genomes of individuals with consanguineous background are enriched for homozygous variants that may unmask dispensable regions of disease genes and unrecognized false positives in diagnostic large-scale sequencing and preconception carrier screening.
- Published
- 2015
- Full Text
- View/download PDF
6. Non-manifesting AHI1 truncations indicate localized loss-of-function tolerance in a severe Mendelian disease gene.
- Author
-
Elsayed, Solaf M., Phillips, Jennifer B., Heller, Raoul, Thoenes, Michaela, Elsobky, Ezzat, Nürnberg, Gudrun, Nürnberg, Peter, Seland, Saskia, Ebermann, Inga, Altmüller, Janine, Thiele, Holger, Toliat, Mohammad, Körber, Friederike, Xue-Jia Hu, Wu, Yun-Dong, Zaki, Maha S., Abdel-Salam, Ghada, Gleeson, Joseph, Boltshauser, Eugen, and Westerfield, Monte
- Published
- 2015
- Full Text
- View/download PDF
7. (AEDPH3)·(ureaH)·(H2O): A Novel Organic Supramolecular Plaster with Gas Adsorption Performance.
- Author
-
Shuo-ping Chen, Le Hu, Xue-jia Hu, Yi-xuan Yuan, Ling-ling Pan, and Liang-jie Yuan
- Published
- 2009
- Full Text
- View/download PDF
8. Erythrocyte membrane-coated gold nanocages for targeted photothermal and chemical cancer therapy.
- Author
-
Dao-Ming Zhu, Wei Xie, Yu-Sha Xiao, Meng Suo, Ming-Hui Zan, Qing-Quan Liao, Xue-Jia Hu, Li-Ben Chen, Bei Chen, Wen-Tao Wu, Li-Wei Ji, Hui-Ming Huang, Shi-Shang Guo, Xing-Zhong Zhao, Quan-Yan Liu, and Wei Liu
- Subjects
CANCER treatment ,GOLD nanoparticles ,ERYTHROCYTE membranes - Abstract
Recently, red blood cell (RBC) membrane-coated nanoparticles have attracted much attention because of their excellent immune escapability; meanwhile, gold nanocages (AuNs) have been extensively used for cancer therapy due to their photothermal effect and drug delivery capability. The combination of the RBC membrane coating and AuNs may provide an effective approach for targeted cancer therapy. However, few reports have shown the utilization of combining these two technologies. Here, we design erythrocyte membrane-coated gold nanocages for targeted photothermal and chemical cancer therapy. First, anti-EpCam antibodies were used to modify the RBC membranes to target 4T1 cancer cells. Second, the antitumor drug paclitaxel (PTX) was encapsulated into AuNs. Then, the AuNs were coated with the modified RBC membranes. These new nanoparticles were termed EpCam–RPAuNs. We characterized the capability of the EpCam–RPAuNs for selective tumor targeting via exposure to near-infrared irradiation. The experimental results demonstrate that EpCam–RPAuNs can effectively generate hyperthermia and precisely deliver the antitumor drug PTX to targeted cells. We also validated the biocompatibility of the EpCam–RAuNs in vitro. By combining the molecularly modified targeting RBC membrane and AuNs, our approach provides a new way to design biomimetic nanoparticles to enhance the surface functionality of nanoparticles. We believe that EpCam–RPAuNs can be potentially applied for cancer diagnoses and therapies. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.